定量系统药理模型用于预测B细胞恶性瘤患者中布鲁顿氨酸激酶抑制剂的位占用率
Oleg Demin1, Ying Ou2, Galina Kolesova1
1InSysBio CY, Limassol, Cyprus.
CPT: pharmacometrics & systems pharmacology
|February 12, 2025
概括
定量系统药理建模将布鲁顿氨酸激酶 (BTK) 抑制剂水平与治疗有效性联系起来. 赞努布鲁丁尼布比伊布鲁丁尼布和阿卡拉布鲁丁尼布的BTK占用率更高,特别是在剂量中断期间,这表明疗效有所改善.
科学领域:
- 药理学 药理学是指药理学的学科.
- 计算生物学 计算生物学
- 在瘤学瘤学.
背景情况:
- 布鲁顿氨酸激酶 (BTK) 抑制剂的有效性取决于标组织的占用率.
- 临床研究表明,在慢性淋巴细胞白血病 (CLL) 中,BTK抑制剂的无进展生存期 (PFS) 是不同的.
研究的目的:
- 将BTK占用量的定量差异与三种共价BTK抑制剂的疗效概况联系起来.
- 开发一个定量系统药理学 (QSP) 模型,用于B细胞恶性瘤中BTK占用.
主要方法:
- 开发了一种QSP模型,描述BTK抑制剂的药理动力学,细胞内度,BTK结合和周转.
- 使用现有的临床BTK占用数据验证了模型.
- 在不同的组织 (PBMC,淋巴结,骨髓) 和临床场景中模拟BTK占用,包括剂量中断.
主要成果:
- 在QSP模型中预测,在PBMC,淋巴结和骨髓中,扎努布鲁丁尼布的BTK占用中位数较高,而伊布鲁丁尼布和阿卡拉布鲁丁尼布的占用中位数较高.
- 在模拟剂量中断期间,BTK占用率的差异比在最低稳定状态时更为显著.
- 模型预测与观察到的临床疗效数据保持一致.
结论:
- 在稳定状态低谷和在治疗中断期间保持高BTK占用率对于最大限度地提高BTK抑制剂的疗效至关重要.
- QSP建模有效地整合了体外和临床数据,以预测具有挑战性的组织中的受体占用率.
- 这种方法提供了对BTK抑制剂之间的差异化疗效的见解.
相关概念视频
01:13Physiological Pharmacokinetic Models: Assumption with Protein Binding
30
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
30
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
26
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
26
01:30Quantitative Aspects of Drug-Receptor Interaction
928
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
928
01:20Pharmacokinetic Models: Overview
558
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
558
01:26Pharmacokinetic Models: Comparison and Selection Criterion
38
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
38
01:15Model Approaches for Pharmacokinetic Data: Physiological Models
28
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
28